GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Cleistrioside-5

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act2211Cleistrioside-5Staphylococcus aureus ATCC33591 (oxacillin-resistant)MIC (μg/mL)210.1021/ml300303g
act2213Cleistrioside-5Coagulase-negative staphylococciMIC (μg/mL)2 - 410.1021/ml300303g
act2215Cleistrioside-5Enterococcus faecalisMIC (μg/mL)210.1021/ml300303g
act2217Cleistrioside-5Bacillus spp.MIC (μg/mL)210.1021/ml300303g
act2219Cleistrioside-5Streptococcus pneumoniaeMIC (μg/mL)4 - 1610.1021/ml300303g
act2221Cleistrioside-5Corynebacterium spp.MIC (μg/mL)810.1021/ml300303g
act2223Cleistrioside-5viridans group streptococciMIC (μg/mL)410.1021/ml300303g
act2225Cleistrioside-5E. coli MG1655MIC (μM)>6410.1021/ml300303g
act2233Cleistrioside-5E. coli impMIC (μM)>6410.1021/ml300303g
act2241Cleistrioside-5B. subtilis JH642MIC (μM)3210.1021/ml300303g
act2249Cleistrioside-5NCI-H460MIC (μM)90.910.1021/ml300303g
act2257Cleistrioside-5RPMI-8226 (leukemia)GI50 (μM)4.1210.1021/ml300303g
act2263Cleistrioside-5SR (leukemia)GI50 (μM)3.2010.1021/ml300303g
act2269Cleistrioside-5A549 (nonsmall cell lung cancer)GI50 (μM)6.6910.1021/ml300303g
act2275Cleistrioside-5NCI-H460 (nonsmall cell lung cancer)GI50 (μM)6.3210.1021/ml300303g
act2281Cleistrioside-5HCT-15 (colon cancer)GI50 (μM)8.3910.1021/ml300303g
act2287Cleistrioside-5HT-29 (colon cancer)GI50 (μM)4.3510.1021/ml300303g
act2293Cleistrioside-5SF-539 (CNS cancer)GI50 (μM)7.1110.1021/ml300303g
act2299Cleistrioside-5SNB-75 (CNS cancer)GI50 (μM)3.4210.1021/ml300303g
act2305Cleistrioside-5MDA-MB-435 (melanoma)GI50 (μM)7.6810.1021/ml300303g
act2311Cleistrioside-5SK-MEL-5 (melanoma)GI50 (μM)6.2110.1021/ml300303g
act2317Cleistrioside-5OVCAR-3 (ovarian cancer)GI50 (μM)5.9110.1021/ml300303g
act2323Cleistrioside-5ADR-R (ovarian cancer)GI50 (μM)9.2910.1021/ml300303g
act2329Cleistrioside-5A498 (renal cancer)GI50 (μM)6.7310.1021/ml300303g
act2335Cleistrioside-5CAKI-1 (renal cancer)GI50 (μM)8.7810.1021/ml300303g
act2341Cleistrioside-5PC-3 (prostate cancer)GI50 (μM)2.3710.1021/ml300303g
act2347Cleistrioside-5DU-145 (prostate cancer)GI50 (μM)7.9410.1021/ml300303g
act2353Cleistrioside-5MCF7 (breast cancer)GI50 (μM)4.8410.1021/ml300303g
act2359Cleistrioside-5BT-549 (breast cancer)GI50 (μM)7.9010.1021/ml300303g